Loss of Bard1, the Heterodimeric Partner of the Brca1 Tumor Suppressor, Results in Early Embryonic Lethality and Chromosomal Instability

REFERENCES

• Abbott, D. W., M. E. Thompson, C. Robinson-Benion, G. Tomlinson, R. A. Jensen, and J. T. Holt. 1999. BRCA1 expression restores radiation resistance in BRCA1-defective cancer cells through enhancement of transcription-coupled DNA repair. J. Biol. Chem. 274: 18808–18812.
   PubMed Web of Science ®Google Scholar
• Baer, R., and T. Ludwig. 2002. The BRCA1/BARD1 heterodimer, a tumor suppressor complex with ubiquitin E3 ligase activity. Curr. Opin. Genet. Dev. 12: 86–91.
   PubMed Web of Science ®Google Scholar
• Bhattacharyya, A., U. S. Ear, B. H. Koller, R. R. Weichselbaum, and D. K. Bishop. 2000. The breast cancer susceptibility gene BRCA1 is required for subnuclear assembly of Rad51 and survival following treatment with the DNA cross-linking agent cisplatin. J. Biol. Chem. 275: 23899–23903.
   PubMed Web of Science ®Google Scholar
• Brodie, S. G., and C. X. Deng. 2001. BRCA1-associated tumorigenesis: what have we learned from knockout mice? Trends Genet. 17: S18–S22.
   PubMedGoogle Scholar
• Brugarolas, J., and T. Jacks. 1997. Double indemnity: p53, BRCA and cancer. p53 mutation partially rescues developmental arrest in Brca1 and Brca2 null mice, suggesting a role for familial breast cancer genes in DNA damage repair. Nat. Med. 3: 721–722.
   PubMedGoogle Scholar
• Brzovic, P. S., P. Rajagopal, D. W. Hoyt, M. C. King, and R. E. Klevit. 2001. Structure of a BRCA1-BARD1 heterodimeric RING-RING complex. Nat. Struct. Biol. 8: 833–837.
   PubMedGoogle Scholar
• Chen, A., F. E. Kleiman, J. L. Manley, T. Ouchi, and Z. Q. Pan. 2002. Autoubiquitination of the BRCA1*BARD1 RING ubiquitin ligase. J. Biol. Chem. 277: 22085–22092.
   PubMed Web of Science ®Google Scholar
• Couch, F. J., B. L. Weber, et al. 1996. Mutations and polymorphisms in the familial early-onset breast cancer (BRCA1) gene. Hum. Mutat. 8: 8–18.
   PubMed Web of Science ®Google Scholar
• Deng, C. X. 2001. Tumorigenesis as a consequence of genetic instability in Brca1 mutant mice. Mutat. Res. 477: 183–189.
   PubMedGoogle Scholar
• Fabbro, M., J. A. Rodriguez, R. Baer, and B. R. Henderson. 2002. BARD1 induces BRCA1 intranuclear foci formation by increasing RING-dependent BRCA1 nuclear import and inhibiting BRCA1 nuclear export. J. Biol. Chem. 277: 21315–21324.
   PubMedGoogle Scholar
• Foray, N., V. Randrianarison, D. Marot, M. Perricaudet, G. Lenoir, and J. Feunteun. 1999. Gamma-rays-induced death of human cells carrying mutations of BRCA1 or BRCA2. Oncogene 18: 7334–7342.
   PubMed Web of Science ®Google Scholar
• Ghimenti, C., E. Sensi, S. Presciuttini, I. M. Brunetti, P. Conte, G. Bevilacqua, and M. A. Caligo. 2002. Germline mutations of the BRCA1-associated ring domain (BARD1) gene in breast and breast/ovarian families negative for BRCA1 and BRCA2 alterations. Genes Chromosomes Cancer 33: 235–242.
   PubMed Web of Science ®Google Scholar
• Gowen, L. C., A. V. Avrutskaya, A. M. Latour, B. H. Koller, and S. A. Leadon. 1998. BRCA1 required for transcription-coupled repair of oxidative DNA damage. Science 281: 1009–1012.
   PubMed Web of Science ®Google Scholar
• Hakem, R., J. L. de la Pompa, A. Elia, J. Potter, and T. W. Mak. 1997. Partial rescue of Brca1 (5-6) early embryonic lethality by p53 or p21 null mutation. Nat. Genet. 16: 298–302.
   PubMed Web of Science ®Google Scholar
• Hakem, R., J. L. de la Pompa, C. Sirard, R. Mo, M. Woo, A. Hakem, A. Wakeham, J. Potter, A. Reitmair, F. Billia, E. Firpo, C. C. Hui, J. Roberts, J. Rossant, and T. W. Mak. 1996. The tumor suppressor gene Brca1 is required for embryonic cellular proliferation in the mouse. Cell 85: 1009–1023.
   PubMed Web of Science ®Google Scholar
• Hartman, A. R., and J. M. Ford. 2002. BRCA1 induces DNA damage recognition factors and enhances nucleotide excision repair. Nat. Genet. 32: 180–184.
   PubMed Web of Science ®Google Scholar
• Hashizume, R., M. Fukuda, I. Maeda, H. Nishikawa, D. Oyake, Y. Yabuki, H. Ogata, and T. Ohta. 2001. The RING heterodimer BRCA1-BARD1 is a ubiquitin ligase inactivated by a breast cancer-derived mutation. J. Biol. Chem. 276: 14537–14540.
   PubMed Web of Science ®Google Scholar
• Hayashi, Y., M. Koike, M. Matsutani, and T. Hoshino. 1988. Effects of fixation time and enzymatic digestion on immunohistochemical demonstration of bromodeoxyuridine in formalin-fixed, paraffin-embedded tissue. J. Histochem. Cytochem. 36: 511–514.
   PubMed Web of Science ®Google Scholar
• Hohenstein, P., M. F. Kielman, C. Breukel, L. M. Bennett, R. Wiseman, P. Krimpenfort, C. Cornelisse, G. J. van Ommen, P. Devilee, and R. Fodde. 2001. A targeted mouse Brca1 mutation removing the last BRCT repeat results in apoptosis and embryonic lethality at the headfold stage. Oncogene 20: 2544–2550.
   PubMedGoogle Scholar
• Irminger-Finger, I., W. C. Leung, J. Li, M. Dubois-Dauphin, J. Harb, A. Feki, C. E. Jefford, J. V. Soriano, M. Jaconi, R. Montesano, and K. H. Krause. 2001. Identification of BARD1 as mediator between proapoptotic stress and p53-dependent apoptosis. Mol. Cell 8: 1255–1266.
   PubMed Web of Science ®Google Scholar
• Jacks, T., L. Remington, B. O. Williams, E. M. Schmitt, S. Halachmi, R. T. Bronson, and R. A. Weinberg. 1994. Tumor spectrum analysis in p53-mutant mice. Curr. Biol. 4: 1–7.
   PubMed Web of Science ®Google Scholar
• Jackson, P. K., A. G. Eldridge, E. Freed, L. Furstenthal, J. Y. Hsu, B. K. Kaiser, and J. D. Reimann. 2000. The lore of the RINGs: substrate recognition and catalysis by ubiquitin ligases. Trends Cell Biol. 10: 429–439.
   PubMed Web of Science ®Google Scholar
• Jin, Y., X. L. Xu, M. C. Yang, F. Wei, T. C. Ayi, A. M. Bowcock, and R. Baer. 1997. Cell cycle-dependent colocalization of BARD1 and BRCA1 proteins in discrete nuclear domains. Proc. Natl. Acad. Sci. USA 94: 12075–12080.
   PubMed Web of Science ®Google Scholar
• Joazeiro, C. A., and A. M. Weissman. 2000. RING finger proteins: mediators of ubiquitin ligase activity. Cell 102: 549–552.
   PubMed Web of Science ®Google Scholar
• Johnson, R. D., and M. Jasin. 2001. Double-strand-break-induced homologous recombination in mammalian cells. Biochem. Soc. Trans. 29: 196–201.
   PubMed Web of Science ®Google Scholar
• Joukov, V., J. Chen, E. A. Fox, J. B. Green, and D. M. Livingston. 2001. Functional communication between endogenous BRCA1 and its partner, BARD1, during Xenopus laevis development. Proc. Natl. Acad. Sci. USA 98: 12078–12083.
   PubMedGoogle Scholar
• Kleiman, F. E., and J. L. Manley. 2001. The BARD1-CstF-50 interaction links mRNA 3′ end formation to DNA damage and tumor suppression. Cell 104: 743–753.
   PubMed Web of Science ®Google Scholar
• Kleiman, F. E., and J. L. Manley. 1999. Functional interaction of BRCA1-associated BARD1 with polyadenylation factor CstF-50. Science 285: 1576–1579.
   PubMed Web of Science ®Google Scholar
• Koonin, E. V., S. F. Altschul, and P. Bork. 1996. BRCA1 protein products… functional motifs. Nat. Genet. 13: 266–268.
   PubMed Web of Science ®Google Scholar
• Le Page, F., V. Randrianarison, D. Marot, J. Cabannes, M. Perricaudet, J. Feunteun, and A. Sarasin. 2000. BRCA1 and BRCA2 are necessary for the transcription-coupled repair of the oxidative 8-oxoguanine lesion in human cells. Cancer Res. 60: 5548–5552.
   PubMed Web of Science ®Google Scholar
• Liu, C. Y., A. Flesken-Nikitin, S. Li, Y. Zeng, and W. H. Lee. 1996. Inactivation of the mouse Brca1 gene leads to failure in the morphogenesis of the egg cylinder in early postimplantation development. Genes Dev. 10: 1835–1843.
   PubMed Web of Science ®Google Scholar
• Lorick, K. L., J. P. Jensen, S. Fang, A. M. Ong, S. Hatakeyama, and A. M. Weissman. 1999. RING fingers mediate ubiquitin-conjugating enzyme (E2)-dependent ubiquitination. Proc. Natl. Acad. Sci. USA 96: 11364–11369.
   PubMed Web of Science ®Google Scholar
• Ludwig, T., D. L. Chapman, V. E. Papaioannou, and A. Efstratiadis. 1997. Targeted mutations of breast cancer susceptibility gene homologs in mice: lethal phenotypes of Brca1, Brca2, Brca1/Brca2, Brca1/p53, and Brca2/p53 nullizygous embryos. Genes Dev. 11: 1226–1241.
   PubMed Web of Science ®Google Scholar
• Miki, Y., J. Swensen, D. Shattuck-Eidens, P. A. Futreal, K. Harshman, S. Tavtigian, Q. Liu, C. Cochran, L. M. Bennett, W. Ding, et al. 1994. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 266: 66–71.
   PubMed Web of Science ®Google Scholar
• Monteiro, A. N. 2000. BRCA1: exploring the links to transcription. Trends Biochem. Sci. 25: 469–474.
   PubMedGoogle Scholar
• Moynahan, M. E., J. W. Chiu, B. H. Koller, and M. Jasin. 1999. Brca1 controls homology-directed DNA repair. Mol. Cell 4: 511–518.
   PubMed Web of Science ®Google Scholar
• Moynahan, M. E., T. Y. Cui, and M. Jasin. 2001. Homology-directed DNA repair, mitomycin-c resistance, and chromosome stability is restored with correction of a Brca1 mutation. Cancer Res. 61: 4842–4850.
   PubMed Web of Science ®Google Scholar
• Orelli, B. J., J. M. Logsdon, Jr., and D. K. Bishop. 2001. Nine novel conserved motifs in BRCA1 identified by the chicken orthologue. Oncogene 20: 4433–4438.
   PubMedGoogle Scholar
• Ruffner, H., C. A. Joazeiro, D. Hemmati, T. Hunter, and I. M. Verma. 2001. Cancer-predisposing mutations within the RING domain of BRCA1: loss of ubiquitin protein ligase activity and protection from radiation hypersensitivity. Proc. Natl. Acad. Sci. USA 98: 5134–5139.
   PubMed Web of Science ®Google Scholar
• Scully, R., J. Chen, A. Plug, Y. Xiao, D. Weaver, J. Feunteun, T. Ashley, and D. M. Livingston. 1997. Association of BRCA1 with Rad51 in mitotic and meiotic cells. Cell 88: 265–275.
   PubMed Web of Science ®Google Scholar
• Scully, R., S. Ganesan, K. Vlasakova, J. Chen, M. Socolovsky, and D. M. Livingston. 1999. Genetic analysis of BRCA1 function in a defined tumor cell line. Mol. Cell 4: 1093–1099.
   PubMed Web of Science ®Google Scholar
• Scully, R., and D. M. Livingston. 2000. In search of the tumour-suppressor functions of BRCA1 and BRCA2. Nature 408: 429–432.
   PubMed Web of Science ®Google Scholar
• Sharan, S. K., M. Morimatsu, U. Albrecht, D. S. Lim, E. Regel, C. Dinh, A. Sands, G. Eichele, P. Hasty, and A. Bradley. 1997. Embryonic lethality and radiation hypersensitivity mediated by Rad51 in mice lacking Brca2. Nature 386: 804–810.
   PubMed Web of Science ®Google Scholar
• Shattuck-Eidens, D., M. McClure, J. Simard, F. Labrie, S. Narod, F. Couch, K. Hoskins, B. Weber, L. Castilla, M. Erdos, et al. 1995. A collaborative survey of 80 mutations in the BRCA1 breast and ovarian cancer susceptibility gene. Implications for presymptomatic testing and screening. JAMA 273: 535–541.
   PubMed Web of Science ®Google Scholar
• Shen, S. X., Z. Weaver, X. Xu, C. Li, M. Weinstein, L. Chen, X. Y. Guan, T. Ried, and C. X. Deng. 1998. A targeted disruption of the murine Brca1 gene causes gamma-irradiation hypersensitivity and genetic instability. Oncogene 17: 3115–3124.
   PubMed Web of Science ®Google Scholar
• Snouwaert, J. N., L. C. Gowen, A. M. Latour, A. R. Mohn, A. Xiao, L. DiBiase, and B. H. Koller. 1999. BRCA1 deficient embryonic stem cells display a decreased homologous recombination frequency and an increased frequency of non-homologous recombination that is corrected by expression of a brca1 transgene. Oncogene 18: 7900–7907.
   PubMedGoogle Scholar
• Suzuki, A., J. L. de la Pompa, R. Hakem, A. Elia, R. Yoshida, R. Mo, H. Nishina, T. Chuang, A. Wakeham, A. Itie, W. Koo, P. Billia, A. Ho, M. Fukumoto, C. C. Hui, and T. W. Mak. 1997. Brca2 is required for embryonic cellular proliferation in the mouse. Genes Dev. 11: 1242–1252.
   PubMed Web of Science ®Google Scholar
• Thai, T. H., F. Du, J. T. Tsan, Y. Jin, A. Phung, M. A. Spillman, H. F. Massa, C. Y. Muller, R. Ashfaq, J. M. Mathis, D. S. Miller, B. J. Trask, R. Baer, and A. M. Bowcock. 1998. Mutations in the BRCA1-associated RING domain (BARD1) gene in primary breast, ovarian and uterine cancers. Hum. Mol. Genet. 7: 195–202.
   PubMed Web of Science ®Google Scholar
• Welcsh, P. L., and M. C. King. 2001. BRCA1 and BRCA2 and the genetics of breast and ovarian cancer. Hum. Mol. Genet. 10: 705–713.
   PubMed Web of Science ®Google Scholar
• Wu, L. C., Z. W. Wang, J. T. Tsan, M. A. Spillman, A. Phung, X. L. Xu, M. C. Yang, L. Y. Hwang, A. M. Bowcock, and R. Baer. 1996. Identification of a RING protein that can interact in vivo with the BRCA1 gene product. Nat. Genet. 14: 430–440.
   PubMed Web of Science ®Google Scholar
• Xu, X., Z. Weaver, S. P. Linke, C. Li, J. Gotay, X. W. Wang, C. C. Harris, T. Ried, and C. X. Deng. 1999. Centrosome amplification and a defective G2-M cell cycle checkpoint induce genetic instability in BRCA1 exon 11 isoform-deficient cells. Mol. Cell 3: 389–395.
   PubMed Web of Science ®Google Scholar
• Yagi, T., Y. Ikawa, K. Yoshida, Y. Shigetani, N. Takeda, I. Mabuchi, T. Yamamoto, and S. Aizawa. 1990. Homologous recombination at c-fyn locus of mouse embryonic stem cells with use of diphtheria toxin A-fragment gene in negative selection. Proc. Natl. Acad. Sci. USA 87: 9918–9922.
   PubMedGoogle Scholar
• Yu, X., and R. Baer. 2000. Nuclear localization and cell cycle-specific expression of CtIP, a protein that associates with the BRCA1 tumor suppressor. J. Biol. Chem. 275: 18541–18549.
   PubMedGoogle Scholar